Pfizer Notes Doctor Decisions In Appeal Of $142M RICO Award
By Greg Ryan ( February 7, 2013, 7:29 PM EST) -- Pfizer Inc. argued to the First Circuit on Wednesday that physicians' independent decisions to prescribe pain drug Neurontin for off-label uses should take the drugmaker off the hook for a $142 million jury award to HMO operator Kaiser Foundation Health Plan Inc....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.